| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Scientific Officer
1 company
Monahan Joseph is a Chief Scientific Officer at Aclaris Therapeutics, Inc.. Recent SEC Form 4 filings include 0 buys and 11 sells.
Estimated insider holdings value: $1.3M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 23, 2023 | ACRS Aclaris Therapeutics, Inc. | Chief Scientific Officer | Sell | 6,000 | $5.08 | $30,460.20 | -4.4% | -74.7% | -74.5% | |
| Aug 21, 2023 | ACRS Aclaris Therapeutics, Inc. | Chief Scientific Officer | Sell | 6,000 | $7.32 | $43,894.80 | -4.2% | -87.2% | -83.0% | |
| Jun 20, 2023 | ACRS Aclaris Therapeutics, Inc. | Chief Scientific Officer | Sell | 6,000 | $10.28 | $61,662.60 | -4.1% | -30.0% | -89.4% | |
| Mar 3, 2023 | ACRS Aclaris Therapeutics, Inc. | Chief Scientific Officer | Sale+OE | 30,837 | $12.51 | $385,638.87 | -9.3% | -31.9% | -90.3% | |
| Feb 15, 2023 | ACRS Aclaris Therapeutics, Inc. | Chief Scientific Officer | Sell | 5,000 | $13.06 | $65,310.50 | -5.2% | -37.5% | -90.6% | |
| Dec 15, 2022 | ACRS Aclaris Therapeutics, Inc. | Chief Scientific Officer | Sell | 5,000 | $15.88 | $79,411.50 | -4.9% | -48.9% | -93.5% | |
| Oct 17, 2022 | ACRS Aclaris Therapeutics, Inc. | Chief Scientific Officer | Sell | 5,000 | $15.98 | $79,907.50 | -4.7% | +11.2% | -65.7% | |
| Apr 18, 2022 | ACRS Aclaris Therapeutics, Inc. | Chief Scientific Officer | Sell | 30,000 | $16.28 | $488,298.00 | -22.0% | -6.4% | -42.4% | |
| Mar 10, 2022 | ACRS Aclaris Therapeutics, Inc. | Chief Scientific Officer | Sell | 27,165 | $15.71 | $426,802.90 | -16.6% | -3.3% | -50.7% | |
| Feb 9, 2022 | ACRS Aclaris Therapeutics, Inc. | Chief Scientific Officer | Sell | 383 | $12.68 | $4,857.13 | -0.4% | -12.7% | +8.8% |